Cover Image

Evaluate the Clinical Outcome of Nanoparticle Albumin-bound Paclitaxel on Breast Cancer Treatment: A Systematic Review and Meta-analysis

Background and aim: Nanoparticle albumin-bound paclitaxel can have a higher response rate than paclitaxel in women with metastatic breast cancer. Therefore, the present study was conducted to evaluate the clinical outcome of nanoparticle albumin-bound paclitaxel on breast cancer treatment.Material a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yasaman Shariati (Author), Fatemeh Salehi Kahrizsangi (Author), Niloofarsadat Hozhabrossadati (Author), Donya Naseri (Author), Mandana Ebrahimi (Author)
Format:	Book
Published:	International Journal of Scientific Research in Dental and Medical Sciences (IJSRDMS), 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of the Clinical Outcome of Nab-paclitaxel on Multiple Primary Malignancies: A Systematic Review and Meta-analysis
by: Fatemeh Salehi Kahrizsangi, et al.
Published: (2022)

Nanoparticle albumin-bound paclitaxel - first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022)

Comparison of Peripheral Neuropathy Induced by Standard and Nanoparticle Albumin-Bound Paclitaxel in Rats
by: Yuji Yamashita, et al.
Published: (2011)

Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients
by: Qingmei Li, et al.
Published: (2018)

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients
by: Fabi A, et al.
Published: (2015)

Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes
by: Sei-ichiro Motegi, et al.
Published: (2019)

Albumin-bound paclitaxel in solid tumors: clinical development and future directions
by: Kundranda MN, et al.
Published: (2015)

Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives
by: Zhichao Tian, et al.
Published: (2024)

Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023)

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life
by: Palumbo R, et al.
Published: (2015)

Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis
by: Yuanqiong Duan, et al.
Published: (2024)

Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
by: Huan Wang, et al.
Published: (2022)

Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein
by: Wenwen Xu, et al.
Published: (2023)

Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy
by: Zaigang Zhou, et al.
Published: (2024)

Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery
by: Yuxin Chen, et al.
Published: (2022)

Risk factors for interstitial lung disease induced by gemcitabine plus albumin-bound paclitaxel therapy in pancreatic ductal adenocarcinoma patients
by: Rikako Ueda, et al.
Published: (2022)

Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration
by: Yoontaek Lee, et al.
Published: (2024)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
by: Lazzaro C, et al.
Published: (2013)

Synergistic effect of microRNA and albumin-bound nanoparticles for inhibition of glioblastoma cancer cell proliferation
by: Maria Shariatnasery, et al.
Published: (2020)

Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma
by: Chunhui Ruan, et al.
Published: (2018)

Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma
by: Xu H, et al.
Published: (2022)

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
by: Jincheng Yang, et al.
Published: (2018)

Bioequivalence of paclitaxel protein-bound particles in patients with breast cancer: determining total and unbound paclitaxel in plasma by rapid equilibrium dialysis and liquid chromatography–tandem mass spectrometry
by: Li J, et al.
Published: (2019)

Pure redox-sensitive paclitaxel-maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency
by: Xinyu Lou, et al.
Published: (2021)

Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models
by: Hang Chen, et al.
Published: (2021)

Chondroitin sulfate-mediated albumin corona nanoparticles for the treatment of breast cancer
by: Tiantian Tan, et al.
Published: (2021)

Investigation of Effective Parameters on Size of Paclitaxel Loaded PLGA Nanoparticles
by: Fatemeh Madani, et al.
Published: (2018)

Design and Characterization of Paclitaxel-Loaded Polymeric Nanoparticles Decorated With Trastuzumab for the Effective Treatment of Breast Cancer
by: Mirina Sakhi, et al.
Published: (2022)

Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel
by: Yanrong Ma, et al.
Published: (2023)

In Vitro Assessment of Magnetic Liposomal Paclitaxel Nanoparticles as a Potential Carrier for the Treatment of Ovarian Cancer
by: Sara Yousefi Aldashi, et al.
Published: (2021)

Insight into the preformed albumin corona on in vitro and in vivo performances of albumin-selective nanoparticles
by: Zhenbao Li, et al.
Published: (2019)

l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells
by: Shiwei Niu, et al.
Published: (2018)

Evaluate the Prognostic Value of Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA: A Systematic Review and Meta-analysis
by: Negar Eghbalifard, et al.
Published: (2024)

Possible Benefits of Paclitaxel Therapy for COVID-19
by: Marzieh Pashmforosh, et al.
Published: (2022)

Combination Therapy with Doxorubicin-Loaded Reduced Albumin Nanoparticles and Focused Ultrasound in Mouse Breast Cancer Xenografts
by: Daehyun Kim, et al.
Published: (2020)

ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models
by: Linxi Zhu, et al.
Published: (2021)

Effect of polymeric stabilizers on the size and stability of PLGA paclitaxel nanoparticles
by: Mirina Sakhi, et al.
Published: (2023)

High Potency of SN-38-Loaded Bovine Serum Albumin Nanoparticles Against Triple-Negative Breast Cancer
by: Hsin-Che Lin, et al.
Published: (2019)

Evaluation of the Role of Exosome-derived MiRNA in Breast Cancer Diagnosis: A Systematic Review and Meta-analysis
by: Pezhman Ghadami, et al.
Published: (2023)

For Treasure Bound
by: Collingwood, Harry, 1851-1922